Pfizer sues Unipharm for violating Viagra patent

Pfizer today filed a NIS 10 million lawsuit with the Tel Aviv District Court against Unipharm for producing and selling imitation Viagra.

Pfizer Inc. (NYSE: PFE; LSE: PFZ) today filed a NIS 10 million lawsuit with the Tel Aviv District Court against Unipharm Ltd. for producing and selling imitation Viagra, in violation of Pfizer's patent. In the statement of claim, Pfizer says that Viagra is one of the most important medical discoveries of the generation and a breakthrough in the treatment of impotence.

Pfizer said that it was astonished to discover that Uniform failed to resist the temptation of making easy profits by producing an imitation Viagra preparation, in violation of its patent on the drug. It is asking the court for an injunction banning Unipharm from selling its preparation, and to order Unipharm to pay NIS 10 million in compensation.

Pfizer added that even before Unipharm began marketing its imitation Viagra, Unipharm proposed a financial settlement to Pfizer for not launching its product. Pfizer rejected the extortion attempt, telling Unipharm that it would enforce its rights.

Published by Globes [online], Israel business news - www.globes-online.com - on May 16, 2013

© Copyright of Globes Publisher Itonut (1983) Ltd. 2013

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018